Illumina Reports Director Departure and Stockholder Meeting
Ticker: ILMN · Form: 8-K · Filed: May 23, 2025 · CIK: 1110803
| Field | Detail |
|---|---|
| Company | Illumina, INC. (ILMN) |
| Form Type | 8-K |
| Filed Date | May 23, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-departure, stockholder-meeting, corporate-governance
Related Tickers: ILMN
TL;DR
Illumina's board sees a change with Dr. Kahn's exit; stockholders voted on key proposals.
AI Summary
On May 21, 2025, Illumina, Inc. filed an 8-K report detailing several key events. The company announced the departure of director Dr. Scott Kahn, effective May 20, 2025. Additionally, Illumina held its annual meeting of stockholders on May 21, 2025, where proposals were submitted to a vote. The filing also includes information regarding compensatory arrangements for certain officers.
Why It Matters
This filing signals a change in board composition and provides updates on corporate governance matters, which can influence investor confidence and strategic direction.
Risk Assessment
Risk Level: low — The filing reports routine corporate events like director departures and stockholder meetings, which typically carry low immediate risk.
Key Players & Entities
- Illumina, Inc. (company) — Registrant
- Dr. Scott Kahn (person) — Departing Director
- May 21, 2025 (date) — Date of Report
- May 20, 2025 (date) — Effective Date of Director Departure
FAQ
Who is the departing director and when was their departure effective?
Dr. Scott Kahn is the departing director, and his departure was effective May 20, 2025.
What was the date of Illumina's annual meeting of stockholders?
The annual meeting of stockholders was held on May 21, 2025.
What type of corporate events are reported in this 8-K?
This 8-K reports the departure of a director, the submission of matters to a vote of security holders, and information on compensatory arrangements of certain officers.
What is the Commission File Number for Illumina, Inc.?
The Commission File Number for Illumina, Inc. is 001-35406.
What is the principal executive office address for Illumina, Inc.?
The principal executive office address is 5200 Illumina Way, San Diego, CA 92122.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 by Dr. Scott Kahn regarding ILLUMINA, INC. (ILMN).